Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency

Ayman A. El-Menyar, Jassim Al Suwaidi, David R. Holmes

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Renal insufficiency (RI) has been shown to be associated with increased major adverse cardiovascular events after percutaneous coronary intervention. We reviewed the impact of RI on the pathogenesis of coronary artery disease and outcomes after percutaneous coronary intervention in the form of drug-eluting stent (DES) implantation in these high-risk patients. We searched the English-language literature indexed in MEDLINE, Scopus, and EBSCO Host research databases from 1990 through January 2009, using as search terms coronary revascularization, drug-eluting stent, and renal insufficiency. Studies that assessed DES implantation in patients with various degrees of RI were selected for review. Most of the available data were extracted from observational studies, and data from randomized trials formed the basis of a post hoc analysis. The outcomes after coronary revascularization were less favorable in patients with RI than in those with normal renal function. In patients with RI, DES implantation yielded better outcomes than did use of bare-metal stents. Randomized trials are needed to define optimal treatment of these high-risk patients with coronary artery disease.

Original languageEnglish (US)
Pages (from-to)165-171
Number of pages7
JournalMayo Clinic proceedings
Issue number2
StatePublished - Feb 2010

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency'. Together they form a unique fingerprint.

Cite this